Cargando…
Effectiveness of Messenger Ribonucleic Acid Vaccine in Lung Transplant Recipients
PURPOSE: Immunization is heralded as a key tool to combat the COVID-19 pandemic. One key technology, messenger RNA (mRNA) vaccines have demonstrated an efficacy greater than 94%(1,2). While mRNA vaccines create strong protection in the majority of patients, the antibody response in solid organ recip...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988645/ http://dx.doi.org/10.1016/j.healun.2022.01.1333 |